GlobeImmune, Inc.
GBIM
$0.0002
$0.000.00%
OTC PK
| 03/31/2016 | 12/31/2015 | 09/30/2015 | 06/30/2015 | 03/31/2015 | |
|---|---|---|---|---|---|
| Net Income | -8.45% | -188.97% | 168.48% | 16.38% | 10.39% |
| Total Depreciation and Amortization | -2.55% | -4.39% | -69.94% | -13.67% | 2.20% |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 43.71% | 113.76% | -372.81% | -15.72% | 422.77% |
| Change in Net Operating Assets | 40.30% | 69.08% | -166.27% | 21.35% | -157.69% |
| Cash from Operations | 14.31% | -7.67% | 33.97% | 18.53% | -19.01% |
| Capital Expenditure | -- | 100.00% | 84.31% | 57.32% | 52.01% |
| Sale of Property, Plant, and Equipment | -- | -94.29% | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -- | -- | -- | -- |
| Cash from Investing | -- | -94.25% | 2,437.25% | 57.32% | 52.01% |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -- | -- | -- | -- | -- |
| Issuance of Common Stock | -- | -- | -- | -- | -- |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -- | -- |
| Cash from Financing | -- | -- | -- | -- | -- |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 13.46% | -30.39% | 46.28% | 18.91% | -18.01% |